High dose thiamine improves fatigue in multiple sclerosis

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Costantini, Antonio ^a   Nappo, Agostino ^a   Pala, Maria Immacolata ^a   Zappone, Antonietta ^a  

^a Department of Neurological Rehabilitation ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; COCARBOXYLASE; GLATIRAMER; THIAMINE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FATIGUE; FATIGUE SEVERITY SCALE; FEMALE; FLUORESCENCE ANALYSIS; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; THIAMINE DEFICIENCY; VITAMIN BLOOD LEVEL;

EID: 84882313653     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-009144     Document Type: Article

References (15)

1. Costantini A, Pala MI. Thiamine and fatigue in inflammatory bowel diseases: an open-label pilot study. J Altern Complement Med. Published Online First: 4 Feb. 2013. doi:10.1089/acm.2011.0840
2. Braley TJ, Chervin RD. Fatigue in multiple sclerosis: mechanisms, evaluation and treatment. Sleep 2010;33:1061-7.
3. World Health Organization. Thiamine deficiency and its prevention and control in major emergencies. Geneva: Department of Nutrition for Heath and Development, WHO; 1999, Report no: WHO/NHD/99. 13.
4. Regenold WT, Phatak P, Makley MJ, et al. Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression. J Neurol Sci 2008;275:106-12.
5. Mahad D, Lassmann H, Turnbull D. Mitochondria and disease progression in multiple sclerosis. Review Neuropathol Appl Neurobiol 2008;34:577-89.
6. Krupp LB, LaRocca NG, Muir-Nash J, et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3. (Pubitemid 19246303)
7. Lee BL, Ong HY, Ong CN. Determination of thiamine and its phosphate esters by gradient-elution high-performance liquid chromatography. J Chromatogr 1991;567:71-80.
8. Smithline HA, Donnino M, Greenblatt DJ. Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjects. BMC Clin Pharmacol 2012;12:4.
9. Lonsdale D. A review of the biochemistry, metabolism and clinical benefits of thiamin (e) and its derivatives. Evid Based Complement Alternat Med 2006;3:49-59. (Pubitemid 43999651)
10. Fauci S, Braunwald E, Kasper DL, et al. Harrison 's principles of internal medicine 17th edn., New York: McGraw-Hill, Inc., 1999.
11. Kono S, Miyajima H, Yoshida K, et al. Mutation in a thiamine-transporter gene and Wernicke's-like encephalopathy. N Engl J Med 2009;360:1792-4.
12. Song Q, Singleton CK. [Mitochondria from cultured cells derived from normal and thiamine-responsive megaloblastic anemia individuals efficiently import thiamine diphosphate]. BMC Biochem 2002;3:8.
13. Krysztofiak B. [Results of the treatment of multiple sclerosis with cocarboxylase]. Neurol Neurochir Psychiatr Pol 1960;10:805-8.
14. Davies SB, Joshua FF, Zagami AS. Wernicke's encephalopathy in a non-alcoholic patient with a normal blood thiamine level. Med J Aust 2011;194:483-4.
15. Costantini A, Pala MI, Colangeli M, et al. Thiamine and spinocerebellar ataxia type 2. BMJ Case Rep. Published Online: 10 Jan 2013. doi:10.1136/bcr- 2012-007302.